Share prices of x-ray vendor Fischer Imaging of Denver took atumble last month after the company announced that it expectedto post disappointing results for its third quarter (end-September).Fischer shares, which had been hovering in the $12-a-share
Share prices of x-ray vendor Fischer Imaging of Denver took atumble last month after the company announced that it expectedto post disappointing results for its third quarter (end-September).Fischer shares, which had been hovering in the $12-a-share rangebefore the announcement, dropped by nearly half and were tradingat under $6 last week.
Fischer said revenues for the quarter are expected to be slightlyhigher, at $20 million compared with $19.1 million in the sameperiod last year. The company's operating earnings will be aboutbreak-even, compared with operating earnings of $1 million inthe third quarter of 1995.
Fischer experienced weaker order rates across its product linesin the third quarter, according to chairman and CEO Morgan Nields.Nields said Fischer would move to cut expenses to counter thelower earnings.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.